Showing results (451-460 of 1,835) with videos related to
Sort By:
Pageof 184
ESMO Open|February 22, 2018
Global cancer control: responding to the growing burden, rising costs and inequalities in accessGerald W Prager, Sofia Braga, Branislav Bystricky, et al.ESMO Open|October 12, 2017
Continuing EGFR-TKI beyond radiological progression in patients with advanced or recurrent, EGFR mutation-positive non-small-cell lung cancer: an observational studyYasushi Goto, Chiharu Tanai, Kiyotaka Yoh, et al.ESMO Open|May 13, 2021
High BRAF variant allele frequencies are associated with distinct pathological features and responsiveness to target therapy in melanoma patientsE Berrino, A Balsamo, A Pisacane, et al.ESMO Open|May 13, 2021
Delayed care for patients with newly diagnosed cancer due to COVID-19 and estimated impact on cancer mortality in FranceJ Y Blay, S Boucher, B Le Vu, et al.ESMO Open|May 13, 2021
Role of surgery and hyperthermic intraperitoneal chemotherapy in ovarian cancerS I Kim, J-W KimESMO Open|April 30, 2021
Patient-reported outcomes from STARTRK-2: a global phase II basket study of entrectinib for ROS1 fusion-positive non-small-cell lung cancer and NTRK fusion-positive solid tumoursL Paz-Ares, F Barlesi, S Siena, et al.ESMO Open|May 1, 2021
The systemic pro-inflammatory response: targeting the dangerous liaison between COVID-19 and cancerG M Dettorre, M Patel, A Gennari, et al.ESMO Open|June 25, 2020
The clinical and cost-effectiveness of supplemental parenteral nutrition in oncologyNeil Webb, Julie Fricke, Elizabeth Hancock, et al.ESMO Open|May 30, 2020
LKB1 mutations are not associated with the efficacy of first-line and second-line chemotherapy in patients with advanced non-small-cell lung cancer (NSCLC): a post hoc analysis of the TAILOR trialClaudio Vernieri, Monica Ganzinelli, Eliana Rulli, et al.ESMO Open|May 16, 2020
How we treat patients with brain tumour during the COVID-19 pandemicMichael Weller, Matthias PreusserPageof 184